Anti-fibrotic therapy in Crohn's disease: hype or reality-can intestinal fibrosis be targeted effectively?
Saved in:
| Title: | Anti-fibrotic therapy in Crohn's disease: hype or reality-can intestinal fibrosis be targeted effectively? |
|---|---|
| Authors: | Honap S; Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London, UK.; School of Immunology and Microbial Sciences, King's College London, London, UK., Dignass A; Department of Medicine I, Agaplesion Markus Hospital, Goethe University, Frankfurt, Germany., Jairath V; Division of Gastroenterology, Department of Medicine, Western University, London, ON, Canada.; Department of Epidemiology and Biostatistics, Western University, London, ON, Canada., Danese S; Department of Gastroenterology and Digestive Endoscopy, IRCCS Ospedale San Raffaele, Milan, Italy., Magro F; CINTESIS@RISE Department, Faculdade de Medicina da Universidade do Porto, Porto, Portugal., Peyrin-Biroulet L; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada. |
| Source: | Expert review of gastroenterology & hepatology [Expert Rev Gastroenterol Hepatol] 2026 Jul; Vol. 20 (7), pp. 627-631. Date of Electronic Publication: 2026 Jun 28. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278199 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1747-4132 (Electronic) Linking ISSN: 17474124 NLM ISO Abbreviation: Expert Rev Gastroenterol Hepatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1747-4132 |
|---|---|
| DOI: | 10.1080/17474124.2026.2695461 |
